---
DrugClass: "[[Cholinergic Drugs]]"
SubClass: "[[Indirect-Acting (Anticholinesterase) Muscle Stimulants]]"
DrugClassContra: "[[Cholinergic Drugs#Contraindications]]"
DrugClassAdverse: "[[Cholinergic Drugs#Side/Adverse Effects]]"
SecondaryDrugClass: 
SecondarySubClass: 
BrandName: Mestinon, Regonol
Chapter: "25"
KindleLinkChap: "[Chapter 25](kindle://book?action=open&asin=B09FRF11YJ&location=13417)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
---
```smiles
C[N+]1=CC=CC(=C1)OC(=O)N(C)C
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
[[ Myasthenia gravis]]
Average dose is 600 mg/ day orally at spaced intervals

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action

### Side/Adverse Effects
See `= this.DrugClassAdverse`
Increased bronchial secretions, cardiac arrhythmias, muscle weakness

### Interactions

`= this.ChemLink+this.file.name`

 